GENES DIS 润色咨询

Genes & Diseases

出版年份：暂无数据 年文章数：481 投稿命中率： 开通期刊会员，数据随心看

出版周期：暂无数据 自引率：暂无数据 审稿周期： 开通期刊会员，数据随心看

前往期刊查询
期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=2145950, encodeId=43082145950e8, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向：hematology<br>经验分享：23-1-28投，2-9建议改rapid communication，2-23改好投回去，2-28under review，4-5minor revise，中间因为事情多延期2月补实验，6-18修回，6-24accept。目前没进一步消息。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=255, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=65db1735433, createdName=1def9298m50(暂无匿称), createdTime=Sun Jul 02 13:26:39 CST 2023, time=2023-07-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2123518, encodeId=77ef212351812, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向：癌症;表观遗传修饰;综述<br>经验分享：已经外审1个多月了，依然没有任何消息，着急的勿投！听说换了出版商，依然很慢，接受了依然未online呀<br>2023.1.28投稿，因格式问题退回修改，过年有事耽误，2023.2.20返回，2023.2.23外审，一直到现在，，，，，外审中。。。。。何时有结果，天知道, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=131, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6ea06468665, createdName=小中医7519, createdTime=Mon Apr 03 17:05:48 CST 2023, time=2023-04-03, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2095357, encodeId=dd2e209535ef3, content=投稿一个多月 还是submit to journal, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=14455530460, createdName=ZNB, createdTime=Sat Oct 22 12:32:00 CST 2022, time=2022-10-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1189040, encodeId=7f9711890406e, content=垃圾 想着国外 投稿三周了没消息 发邮件问不会 直接撤回了 浪费时间, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=56665685878, createdName=ms4000001286605589, createdTime=Sat Jan 29 09:53:50 CST 2022, time=2022-01-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2158337, encodeId=ed29215833e0c, content=审稿速度:3.0 | 投稿命中率:75.0<br>偏重的研究方向：癌症;表观遗传;耐药<br>经验分享：4月份接受，7月出官网online，但到10月份这个也检索不到，问编辑说到明年1月份WOSonline，今年国家奖学金没了，三篇1区SCI，7.4，7.5，6.8，还有中文核心4篇, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=302, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6ea06468665, createdName=小中医7519, createdTime=Mon Sep 18 21:00:36 CST 2023, time=2023-09-18, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2172360, encodeId=feea21e2360a5, content=审稿速度:1.0 | 投稿命中率:75.0<br>经验分享：请问投过这个杂志的前辈都是多久online的，7月4号接收，7月18号就完成了校稿，也交过了版面费，但是都四个多月了一直没有online，检索不到，发邮件给的回复是他也回答不了这个问题，大概要等多久啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=261, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a37c5495661, createdName=whynot6688, createdTime=Fri Dec 01 15:59:33 CST 2023, time=2023-12-01, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=800506, encodeId=42d680050654, content=本刊论文被重庆医科大学包圆了，内容五花八门，低劣水平居多，且很多跟刊物主题相关度不大。强烈建议改名：重庆医科大学学报（英文版）！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=210, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e9e32216429, createdName=pendrin_89355954, createdTime=Tue Jun 30 08:28:03 CST 2020, time=2020-06-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1203114, encodeId=fe7e1203114c9, content=审稿速度:12.0 | 投稿命中率:25.0<br>经验分享：22年的文章很多都是20年接受的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=192, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f0ee5612681, createdName=ms2000001542264371, createdTime=Wed Mar 16 14:46:06 CST 2022, time=2022-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2166032, encodeId=2524216603269, content=请教一下没有under review 就Decision in Process是要被拒了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e06e2311249, createdName=328674612_67739431, createdTime=Wed Nov 01 10:51:38 CST 2023, time=2023-11-01, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2138652, encodeId=a343213865266, content=请教各位前辈们，我查了官网没有发现投稿文章文本的格式，是对字体字号没要求吗。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=266, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c8478710310, createdName=ms6000000438436254, createdTime=Tue May 23 20:28:59 CST 2023, time=2023-05-23, status=1, ipAttribution=广东省)]
    2023-07-02 1def9298m50(暂无匿称)

    审稿速度:1.0 | 投稿命中率:75.0
    偏重的研究方向：hematology
    经验分享：23-1-28投，2-9建议改rapid communication，2-23改好投回去，2-28under review，4-5minor revise，中间因为事情多延期2月补实验，6-18修回，6-24accept。目前没进一步消息。

    3

    展开3条回复
  2. [GetPortalCommentsPageByObjectIdResponse(id=2145950, encodeId=43082145950e8, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向：hematology<br>经验分享：23-1-28投，2-9建议改rapid communication，2-23改好投回去，2-28under review，4-5minor revise，中间因为事情多延期2月补实验，6-18修回，6-24accept。目前没进一步消息。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=255, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=65db1735433, createdName=1def9298m50(暂无匿称), createdTime=Sun Jul 02 13:26:39 CST 2023, time=2023-07-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2123518, encodeId=77ef212351812, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向：癌症;表观遗传修饰;综述<br>经验分享：已经外审1个多月了，依然没有任何消息，着急的勿投！听说换了出版商，依然很慢，接受了依然未online呀<br>2023.1.28投稿，因格式问题退回修改，过年有事耽误，2023.2.20返回，2023.2.23外审，一直到现在，，，，，外审中。。。。。何时有结果，天知道, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=131, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6ea06468665, createdName=小中医7519, createdTime=Mon Apr 03 17:05:48 CST 2023, time=2023-04-03, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2095357, encodeId=dd2e209535ef3, content=投稿一个多月 还是submit to journal, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=14455530460, createdName=ZNB, createdTime=Sat Oct 22 12:32:00 CST 2022, time=2022-10-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1189040, encodeId=7f9711890406e, content=垃圾 想着国外 投稿三周了没消息 发邮件问不会 直接撤回了 浪费时间, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=56665685878, createdName=ms4000001286605589, createdTime=Sat Jan 29 09:53:50 CST 2022, time=2022-01-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2158337, encodeId=ed29215833e0c, content=审稿速度:3.0 | 投稿命中率:75.0<br>偏重的研究方向：癌症;表观遗传;耐药<br>经验分享：4月份接受，7月出官网online，但到10月份这个也检索不到，问编辑说到明年1月份WOSonline，今年国家奖学金没了，三篇1区SCI，7.4，7.5，6.8，还有中文核心4篇, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=302, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6ea06468665, createdName=小中医7519, createdTime=Mon Sep 18 21:00:36 CST 2023, time=2023-09-18, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2172360, encodeId=feea21e2360a5, content=审稿速度:1.0 | 投稿命中率:75.0<br>经验分享：请问投过这个杂志的前辈都是多久online的，7月4号接收，7月18号就完成了校稿，也交过了版面费，但是都四个多月了一直没有online，检索不到，发邮件给的回复是他也回答不了这个问题，大概要等多久啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=261, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a37c5495661, createdName=whynot6688, createdTime=Fri Dec 01 15:59:33 CST 2023, time=2023-12-01, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=800506, encodeId=42d680050654, content=本刊论文被重庆医科大学包圆了，内容五花八门，低劣水平居多，且很多跟刊物主题相关度不大。强烈建议改名：重庆医科大学学报（英文版）！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=210, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e9e32216429, createdName=pendrin_89355954, createdTime=Tue Jun 30 08:28:03 CST 2020, time=2020-06-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1203114, encodeId=fe7e1203114c9, content=审稿速度:12.0 | 投稿命中率:25.0<br>经验分享：22年的文章很多都是20年接受的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=192, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f0ee5612681, createdName=ms2000001542264371, createdTime=Wed Mar 16 14:46:06 CST 2022, time=2022-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2166032, encodeId=2524216603269, content=请教一下没有under review 就Decision in Process是要被拒了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e06e2311249, createdName=328674612_67739431, createdTime=Wed Nov 01 10:51:38 CST 2023, time=2023-11-01, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2138652, encodeId=a343213865266, content=请教各位前辈们，我查了官网没有发现投稿文章文本的格式，是对字体字号没要求吗。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=266, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c8478710310, createdName=ms6000000438436254, createdTime=Tue May 23 20:28:59 CST 2023, time=2023-05-23, status=1, ipAttribution=广东省)]
    2023-04-03 小中医7519 来自天津

    审稿速度:6.0 | 投稿命中率:50.0
    偏重的研究方向：癌症;表观遗传修饰;综述
    经验分享：已经外审1个多月了，依然没有任何消息，着急的勿投！听说换了出版商，依然很慢，接受了依然未online呀
    2023.1.28投稿，因格式问题退回修改，过年有事耽误，2023.2.20返回，2023.2.23外审，一直到现在，，，，，外审中。。。。。何时有结果，天知道

    3

    展开3条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=2145950, encodeId=43082145950e8, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向：hematology<br>经验分享：23-1-28投，2-9建议改rapid communication，2-23改好投回去，2-28under review，4-5minor revise，中间因为事情多延期2月补实验，6-18修回，6-24accept。目前没进一步消息。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=255, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=65db1735433, createdName=1def9298m50(暂无匿称), createdTime=Sun Jul 02 13:26:39 CST 2023, time=2023-07-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2123518, encodeId=77ef212351812, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向：癌症;表观遗传修饰;综述<br>经验分享：已经外审1个多月了，依然没有任何消息，着急的勿投！听说换了出版商，依然很慢，接受了依然未online呀<br>2023.1.28投稿，因格式问题退回修改，过年有事耽误，2023.2.20返回，2023.2.23外审，一直到现在，，，，，外审中。。。。。何时有结果，天知道, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=131, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6ea06468665, createdName=小中医7519, createdTime=Mon Apr 03 17:05:48 CST 2023, time=2023-04-03, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2095357, encodeId=dd2e209535ef3, content=投稿一个多月 还是submit to journal, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=14455530460, createdName=ZNB, createdTime=Sat Oct 22 12:32:00 CST 2022, time=2022-10-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1189040, encodeId=7f9711890406e, content=垃圾 想着国外 投稿三周了没消息 发邮件问不会 直接撤回了 浪费时间, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=56665685878, createdName=ms4000001286605589, createdTime=Sat Jan 29 09:53:50 CST 2022, time=2022-01-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2158337, encodeId=ed29215833e0c, content=审稿速度:3.0 | 投稿命中率:75.0<br>偏重的研究方向：癌症;表观遗传;耐药<br>经验分享：4月份接受，7月出官网online，但到10月份这个也检索不到，问编辑说到明年1月份WOSonline，今年国家奖学金没了，三篇1区SCI，7.4，7.5，6.8，还有中文核心4篇, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=302, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6ea06468665, createdName=小中医7519, createdTime=Mon Sep 18 21:00:36 CST 2023, time=2023-09-18, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2172360, encodeId=feea21e2360a5, content=审稿速度:1.0 | 投稿命中率:75.0<br>经验分享：请问投过这个杂志的前辈都是多久online的，7月4号接收，7月18号就完成了校稿，也交过了版面费，但是都四个多月了一直没有online，检索不到，发邮件给的回复是他也回答不了这个问题，大概要等多久啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=261, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a37c5495661, createdName=whynot6688, createdTime=Fri Dec 01 15:59:33 CST 2023, time=2023-12-01, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=800506, encodeId=42d680050654, content=本刊论文被重庆医科大学包圆了，内容五花八门，低劣水平居多，且很多跟刊物主题相关度不大。强烈建议改名：重庆医科大学学报（英文版）！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=210, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e9e32216429, createdName=pendrin_89355954, createdTime=Tue Jun 30 08:28:03 CST 2020, time=2020-06-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1203114, encodeId=fe7e1203114c9, content=审稿速度:12.0 | 投稿命中率:25.0<br>经验分享：22年的文章很多都是20年接受的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=192, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f0ee5612681, createdName=ms2000001542264371, createdTime=Wed Mar 16 14:46:06 CST 2022, time=2022-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2166032, encodeId=2524216603269, content=请教一下没有under review 就Decision in Process是要被拒了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e06e2311249, createdName=328674612_67739431, createdTime=Wed Nov 01 10:51:38 CST 2023, time=2023-11-01, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2138652, encodeId=a343213865266, content=请教各位前辈们，我查了官网没有发现投稿文章文本的格式，是对字体字号没要求吗。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=266, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c8478710310, createdName=ms6000000438436254, createdTime=Tue May 23 20:28:59 CST 2023, time=2023-05-23, status=1, ipAttribution=广东省)]
    2022-10-22 ZNB

    投稿一个多月 还是submit to journal

    3

    展开3条回复
  4. [GetPortalCommentsPageByObjectIdResponse(id=2145950, encodeId=43082145950e8, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向：hematology<br>经验分享：23-1-28投，2-9建议改rapid communication，2-23改好投回去，2-28under review，4-5minor revise，中间因为事情多延期2月补实验，6-18修回，6-24accept。目前没进一步消息。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=255, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=65db1735433, createdName=1def9298m50(暂无匿称), createdTime=Sun Jul 02 13:26:39 CST 2023, time=2023-07-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2123518, encodeId=77ef212351812, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向：癌症;表观遗传修饰;综述<br>经验分享：已经外审1个多月了，依然没有任何消息，着急的勿投！听说换了出版商，依然很慢，接受了依然未online呀<br>2023.1.28投稿，因格式问题退回修改，过年有事耽误，2023.2.20返回，2023.2.23外审，一直到现在，，，，，外审中。。。。。何时有结果，天知道, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=131, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6ea06468665, createdName=小中医7519, createdTime=Mon Apr 03 17:05:48 CST 2023, time=2023-04-03, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2095357, encodeId=dd2e209535ef3, content=投稿一个多月 还是submit to journal, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=14455530460, createdName=ZNB, createdTime=Sat Oct 22 12:32:00 CST 2022, time=2022-10-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1189040, encodeId=7f9711890406e, content=垃圾 想着国外 投稿三周了没消息 发邮件问不会 直接撤回了 浪费时间, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=56665685878, createdName=ms4000001286605589, createdTime=Sat Jan 29 09:53:50 CST 2022, time=2022-01-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2158337, encodeId=ed29215833e0c, content=审稿速度:3.0 | 投稿命中率:75.0<br>偏重的研究方向：癌症;表观遗传;耐药<br>经验分享：4月份接受，7月出官网online，但到10月份这个也检索不到，问编辑说到明年1月份WOSonline，今年国家奖学金没了，三篇1区SCI，7.4，7.5，6.8，还有中文核心4篇, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=302, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6ea06468665, createdName=小中医7519, createdTime=Mon Sep 18 21:00:36 CST 2023, time=2023-09-18, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2172360, encodeId=feea21e2360a5, content=审稿速度:1.0 | 投稿命中率:75.0<br>经验分享：请问投过这个杂志的前辈都是多久online的，7月4号接收，7月18号就完成了校稿，也交过了版面费，但是都四个多月了一直没有online，检索不到，发邮件给的回复是他也回答不了这个问题，大概要等多久啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=261, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a37c5495661, createdName=whynot6688, createdTime=Fri Dec 01 15:59:33 CST 2023, time=2023-12-01, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=800506, encodeId=42d680050654, content=本刊论文被重庆医科大学包圆了，内容五花八门，低劣水平居多，且很多跟刊物主题相关度不大。强烈建议改名：重庆医科大学学报（英文版）！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=210, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e9e32216429, createdName=pendrin_89355954, createdTime=Tue Jun 30 08:28:03 CST 2020, time=2020-06-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1203114, encodeId=fe7e1203114c9, content=审稿速度:12.0 | 投稿命中率:25.0<br>经验分享：22年的文章很多都是20年接受的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=192, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f0ee5612681, createdName=ms2000001542264371, createdTime=Wed Mar 16 14:46:06 CST 2022, time=2022-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2166032, encodeId=2524216603269, content=请教一下没有under review 就Decision in Process是要被拒了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e06e2311249, createdName=328674612_67739431, createdTime=Wed Nov 01 10:51:38 CST 2023, time=2023-11-01, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2138652, encodeId=a343213865266, content=请教各位前辈们，我查了官网没有发现投稿文章文本的格式，是对字体字号没要求吗。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=266, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c8478710310, createdName=ms6000000438436254, createdTime=Tue May 23 20:28:59 CST 2023, time=2023-05-23, status=1, ipAttribution=广东省)]
    2022-01-29 ms4000001286605589

    垃圾 想着国外 投稿三周了没消息 发邮件问不会 直接撤回了 浪费时间

    3

    展开3条回复
  5. [GetPortalCommentsPageByObjectIdResponse(id=2145950, encodeId=43082145950e8, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向：hematology<br>经验分享：23-1-28投，2-9建议改rapid communication，2-23改好投回去，2-28under review，4-5minor revise，中间因为事情多延期2月补实验，6-18修回，6-24accept。目前没进一步消息。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=255, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=65db1735433, createdName=1def9298m50(暂无匿称), createdTime=Sun Jul 02 13:26:39 CST 2023, time=2023-07-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2123518, encodeId=77ef212351812, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向：癌症;表观遗传修饰;综述<br>经验分享：已经外审1个多月了，依然没有任何消息，着急的勿投！听说换了出版商，依然很慢，接受了依然未online呀<br>2023.1.28投稿，因格式问题退回修改，过年有事耽误，2023.2.20返回，2023.2.23外审，一直到现在，，，，，外审中。。。。。何时有结果，天知道, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=131, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6ea06468665, createdName=小中医7519, createdTime=Mon Apr 03 17:05:48 CST 2023, time=2023-04-03, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2095357, encodeId=dd2e209535ef3, content=投稿一个多月 还是submit to journal, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=14455530460, createdName=ZNB, createdTime=Sat Oct 22 12:32:00 CST 2022, time=2022-10-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1189040, encodeId=7f9711890406e, content=垃圾 想着国外 投稿三周了没消息 发邮件问不会 直接撤回了 浪费时间, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=56665685878, createdName=ms4000001286605589, createdTime=Sat Jan 29 09:53:50 CST 2022, time=2022-01-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2158337, encodeId=ed29215833e0c, content=审稿速度:3.0 | 投稿命中率:75.0<br>偏重的研究方向：癌症;表观遗传;耐药<br>经验分享：4月份接受，7月出官网online，但到10月份这个也检索不到，问编辑说到明年1月份WOSonline，今年国家奖学金没了，三篇1区SCI，7.4，7.5，6.8，还有中文核心4篇, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=302, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6ea06468665, createdName=小中医7519, createdTime=Mon Sep 18 21:00:36 CST 2023, time=2023-09-18, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2172360, encodeId=feea21e2360a5, content=审稿速度:1.0 | 投稿命中率:75.0<br>经验分享：请问投过这个杂志的前辈都是多久online的，7月4号接收，7月18号就完成了校稿，也交过了版面费，但是都四个多月了一直没有online，检索不到，发邮件给的回复是他也回答不了这个问题，大概要等多久啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=261, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a37c5495661, createdName=whynot6688, createdTime=Fri Dec 01 15:59:33 CST 2023, time=2023-12-01, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=800506, encodeId=42d680050654, content=本刊论文被重庆医科大学包圆了，内容五花八门，低劣水平居多，且很多跟刊物主题相关度不大。强烈建议改名：重庆医科大学学报（英文版）！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=210, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e9e32216429, createdName=pendrin_89355954, createdTime=Tue Jun 30 08:28:03 CST 2020, time=2020-06-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1203114, encodeId=fe7e1203114c9, content=审稿速度:12.0 | 投稿命中率:25.0<br>经验分享：22年的文章很多都是20年接受的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=192, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f0ee5612681, createdName=ms2000001542264371, createdTime=Wed Mar 16 14:46:06 CST 2022, time=2022-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2166032, encodeId=2524216603269, content=请教一下没有under review 就Decision in Process是要被拒了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e06e2311249, createdName=328674612_67739431, createdTime=Wed Nov 01 10:51:38 CST 2023, time=2023-11-01, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2138652, encodeId=a343213865266, content=请教各位前辈们，我查了官网没有发现投稿文章文本的格式，是对字体字号没要求吗。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=266, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c8478710310, createdName=ms6000000438436254, createdTime=Tue May 23 20:28:59 CST 2023, time=2023-05-23, status=1, ipAttribution=广东省)]
    2023-09-18 小中医7519 来自天津

    审稿速度:3.0 | 投稿命中率:75.0
    偏重的研究方向：癌症;表观遗传;耐药
    经验分享：4月份接受，7月出官网online，但到10月份这个也检索不到，问编辑说到明年1月份WOSonline，今年国家奖学金没了，三篇1区SCI，7.4，7.5，6.8，还有中文核心4篇

    2

    展开2条回复
  6. [GetPortalCommentsPageByObjectIdResponse(id=2145950, encodeId=43082145950e8, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向：hematology<br>经验分享：23-1-28投，2-9建议改rapid communication，2-23改好投回去，2-28under review，4-5minor revise，中间因为事情多延期2月补实验，6-18修回，6-24accept。目前没进一步消息。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=255, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=65db1735433, createdName=1def9298m50(暂无匿称), createdTime=Sun Jul 02 13:26:39 CST 2023, time=2023-07-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2123518, encodeId=77ef212351812, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向：癌症;表观遗传修饰;综述<br>经验分享：已经外审1个多月了，依然没有任何消息，着急的勿投！听说换了出版商，依然很慢，接受了依然未online呀<br>2023.1.28投稿，因格式问题退回修改，过年有事耽误，2023.2.20返回，2023.2.23外审，一直到现在，，，，，外审中。。。。。何时有结果，天知道, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=131, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6ea06468665, createdName=小中医7519, createdTime=Mon Apr 03 17:05:48 CST 2023, time=2023-04-03, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2095357, encodeId=dd2e209535ef3, content=投稿一个多月 还是submit to journal, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=14455530460, createdName=ZNB, createdTime=Sat Oct 22 12:32:00 CST 2022, time=2022-10-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1189040, encodeId=7f9711890406e, content=垃圾 想着国外 投稿三周了没消息 发邮件问不会 直接撤回了 浪费时间, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=56665685878, createdName=ms4000001286605589, createdTime=Sat Jan 29 09:53:50 CST 2022, time=2022-01-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2158337, encodeId=ed29215833e0c, content=审稿速度:3.0 | 投稿命中率:75.0<br>偏重的研究方向：癌症;表观遗传;耐药<br>经验分享：4月份接受，7月出官网online，但到10月份这个也检索不到，问编辑说到明年1月份WOSonline，今年国家奖学金没了，三篇1区SCI，7.4，7.5，6.8，还有中文核心4篇, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=302, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6ea06468665, createdName=小中医7519, createdTime=Mon Sep 18 21:00:36 CST 2023, time=2023-09-18, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2172360, encodeId=feea21e2360a5, content=审稿速度:1.0 | 投稿命中率:75.0<br>经验分享：请问投过这个杂志的前辈都是多久online的，7月4号接收，7月18号就完成了校稿，也交过了版面费，但是都四个多月了一直没有online，检索不到，发邮件给的回复是他也回答不了这个问题，大概要等多久啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=261, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a37c5495661, createdName=whynot6688, createdTime=Fri Dec 01 15:59:33 CST 2023, time=2023-12-01, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=800506, encodeId=42d680050654, content=本刊论文被重庆医科大学包圆了，内容五花八门，低劣水平居多，且很多跟刊物主题相关度不大。强烈建议改名：重庆医科大学学报（英文版）！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=210, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e9e32216429, createdName=pendrin_89355954, createdTime=Tue Jun 30 08:28:03 CST 2020, time=2020-06-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1203114, encodeId=fe7e1203114c9, content=审稿速度:12.0 | 投稿命中率:25.0<br>经验分享：22年的文章很多都是20年接受的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=192, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f0ee5612681, createdName=ms2000001542264371, createdTime=Wed Mar 16 14:46:06 CST 2022, time=2022-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2166032, encodeId=2524216603269, content=请教一下没有under review 就Decision in Process是要被拒了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e06e2311249, createdName=328674612_67739431, createdTime=Wed Nov 01 10:51:38 CST 2023, time=2023-11-01, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2138652, encodeId=a343213865266, content=请教各位前辈们，我查了官网没有发现投稿文章文本的格式，是对字体字号没要求吗。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=266, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c8478710310, createdName=ms6000000438436254, createdTime=Tue May 23 20:28:59 CST 2023, time=2023-05-23, status=1, ipAttribution=广东省)]
    2023-12-01 whynot6688 来自广东省

    审稿速度:1.0 | 投稿命中率:75.0
    经验分享：请问投过这个杂志的前辈都是多久online的，7月4号接收，7月18号就完成了校稿，也交过了版面费，但是都四个多月了一直没有online，检索不到，发邮件给的回复是他也回答不了这个问题，大概要等多久啊？

    2

    展开2条回复
  7. [GetPortalCommentsPageByObjectIdResponse(id=2145950, encodeId=43082145950e8, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向：hematology<br>经验分享：23-1-28投，2-9建议改rapid communication，2-23改好投回去，2-28under review，4-5minor revise，中间因为事情多延期2月补实验，6-18修回，6-24accept。目前没进一步消息。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=255, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=65db1735433, createdName=1def9298m50(暂无匿称), createdTime=Sun Jul 02 13:26:39 CST 2023, time=2023-07-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2123518, encodeId=77ef212351812, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向：癌症;表观遗传修饰;综述<br>经验分享：已经外审1个多月了，依然没有任何消息，着急的勿投！听说换了出版商，依然很慢，接受了依然未online呀<br>2023.1.28投稿，因格式问题退回修改，过年有事耽误，2023.2.20返回，2023.2.23外审，一直到现在，，，，，外审中。。。。。何时有结果，天知道, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=131, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6ea06468665, createdName=小中医7519, createdTime=Mon Apr 03 17:05:48 CST 2023, time=2023-04-03, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2095357, encodeId=dd2e209535ef3, content=投稿一个多月 还是submit to journal, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=14455530460, createdName=ZNB, createdTime=Sat Oct 22 12:32:00 CST 2022, time=2022-10-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1189040, encodeId=7f9711890406e, content=垃圾 想着国外 投稿三周了没消息 发邮件问不会 直接撤回了 浪费时间, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=56665685878, createdName=ms4000001286605589, createdTime=Sat Jan 29 09:53:50 CST 2022, time=2022-01-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2158337, encodeId=ed29215833e0c, content=审稿速度:3.0 | 投稿命中率:75.0<br>偏重的研究方向：癌症;表观遗传;耐药<br>经验分享：4月份接受，7月出官网online，但到10月份这个也检索不到，问编辑说到明年1月份WOSonline，今年国家奖学金没了，三篇1区SCI，7.4，7.5，6.8，还有中文核心4篇, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=302, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6ea06468665, createdName=小中医7519, createdTime=Mon Sep 18 21:00:36 CST 2023, time=2023-09-18, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2172360, encodeId=feea21e2360a5, content=审稿速度:1.0 | 投稿命中率:75.0<br>经验分享：请问投过这个杂志的前辈都是多久online的，7月4号接收，7月18号就完成了校稿，也交过了版面费，但是都四个多月了一直没有online，检索不到，发邮件给的回复是他也回答不了这个问题，大概要等多久啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=261, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a37c5495661, createdName=whynot6688, createdTime=Fri Dec 01 15:59:33 CST 2023, time=2023-12-01, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=800506, encodeId=42d680050654, content=本刊论文被重庆医科大学包圆了，内容五花八门，低劣水平居多，且很多跟刊物主题相关度不大。强烈建议改名：重庆医科大学学报（英文版）！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=210, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e9e32216429, createdName=pendrin_89355954, createdTime=Tue Jun 30 08:28:03 CST 2020, time=2020-06-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1203114, encodeId=fe7e1203114c9, content=审稿速度:12.0 | 投稿命中率:25.0<br>经验分享：22年的文章很多都是20年接受的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=192, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f0ee5612681, createdName=ms2000001542264371, createdTime=Wed Mar 16 14:46:06 CST 2022, time=2022-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2166032, encodeId=2524216603269, content=请教一下没有under review 就Decision in Process是要被拒了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e06e2311249, createdName=328674612_67739431, createdTime=Wed Nov 01 10:51:38 CST 2023, time=2023-11-01, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2138652, encodeId=a343213865266, content=请教各位前辈们，我查了官网没有发现投稿文章文本的格式，是对字体字号没要求吗。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=266, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c8478710310, createdName=ms6000000438436254, createdTime=Tue May 23 20:28:59 CST 2023, time=2023-05-23, status=1, ipAttribution=广东省)]
    2020-06-30 pendrin_89355954

    本刊论文被重庆医科大学包圆了，内容五花八门，低劣水平居多，且很多跟刊物主题相关度不大。强烈建议改名：重庆医科大学学报（英文版）！

    2

    展开2条回复
  8. [GetPortalCommentsPageByObjectIdResponse(id=2145950, encodeId=43082145950e8, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向：hematology<br>经验分享：23-1-28投，2-9建议改rapid communication，2-23改好投回去，2-28under review，4-5minor revise，中间因为事情多延期2月补实验，6-18修回，6-24accept。目前没进一步消息。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=255, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=65db1735433, createdName=1def9298m50(暂无匿称), createdTime=Sun Jul 02 13:26:39 CST 2023, time=2023-07-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2123518, encodeId=77ef212351812, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向：癌症;表观遗传修饰;综述<br>经验分享：已经外审1个多月了，依然没有任何消息，着急的勿投！听说换了出版商，依然很慢，接受了依然未online呀<br>2023.1.28投稿，因格式问题退回修改，过年有事耽误，2023.2.20返回，2023.2.23外审，一直到现在，，，，，外审中。。。。。何时有结果，天知道, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=131, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6ea06468665, createdName=小中医7519, createdTime=Mon Apr 03 17:05:48 CST 2023, time=2023-04-03, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2095357, encodeId=dd2e209535ef3, content=投稿一个多月 还是submit to journal, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=14455530460, createdName=ZNB, createdTime=Sat Oct 22 12:32:00 CST 2022, time=2022-10-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1189040, encodeId=7f9711890406e, content=垃圾 想着国外 投稿三周了没消息 发邮件问不会 直接撤回了 浪费时间, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=56665685878, createdName=ms4000001286605589, createdTime=Sat Jan 29 09:53:50 CST 2022, time=2022-01-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2158337, encodeId=ed29215833e0c, content=审稿速度:3.0 | 投稿命中率:75.0<br>偏重的研究方向：癌症;表观遗传;耐药<br>经验分享：4月份接受，7月出官网online，但到10月份这个也检索不到，问编辑说到明年1月份WOSonline，今年国家奖学金没了，三篇1区SCI，7.4，7.5，6.8，还有中文核心4篇, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=302, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6ea06468665, createdName=小中医7519, createdTime=Mon Sep 18 21:00:36 CST 2023, time=2023-09-18, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2172360, encodeId=feea21e2360a5, content=审稿速度:1.0 | 投稿命中率:75.0<br>经验分享：请问投过这个杂志的前辈都是多久online的，7月4号接收，7月18号就完成了校稿，也交过了版面费，但是都四个多月了一直没有online，检索不到，发邮件给的回复是他也回答不了这个问题，大概要等多久啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=261, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a37c5495661, createdName=whynot6688, createdTime=Fri Dec 01 15:59:33 CST 2023, time=2023-12-01, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=800506, encodeId=42d680050654, content=本刊论文被重庆医科大学包圆了，内容五花八门，低劣水平居多，且很多跟刊物主题相关度不大。强烈建议改名：重庆医科大学学报（英文版）！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=210, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e9e32216429, createdName=pendrin_89355954, createdTime=Tue Jun 30 08:28:03 CST 2020, time=2020-06-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1203114, encodeId=fe7e1203114c9, content=审稿速度:12.0 | 投稿命中率:25.0<br>经验分享：22年的文章很多都是20年接受的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=192, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f0ee5612681, createdName=ms2000001542264371, createdTime=Wed Mar 16 14:46:06 CST 2022, time=2022-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2166032, encodeId=2524216603269, content=请教一下没有under review 就Decision in Process是要被拒了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e06e2311249, createdName=328674612_67739431, createdTime=Wed Nov 01 10:51:38 CST 2023, time=2023-11-01, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2138652, encodeId=a343213865266, content=请教各位前辈们，我查了官网没有发现投稿文章文本的格式，是对字体字号没要求吗。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=266, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c8478710310, createdName=ms6000000438436254, createdTime=Tue May 23 20:28:59 CST 2023, time=2023-05-23, status=1, ipAttribution=广东省)]
    2022-03-16 ms2000001542264371

    审稿速度:12.0 | 投稿命中率:25.0
    经验分享：22年的文章很多都是20年接受的

    2

    展开2条回复
  9. [GetPortalCommentsPageByObjectIdResponse(id=2145950, encodeId=43082145950e8, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向：hematology<br>经验分享：23-1-28投，2-9建议改rapid communication，2-23改好投回去，2-28under review，4-5minor revise，中间因为事情多延期2月补实验，6-18修回，6-24accept。目前没进一步消息。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=255, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=65db1735433, createdName=1def9298m50(暂无匿称), createdTime=Sun Jul 02 13:26:39 CST 2023, time=2023-07-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2123518, encodeId=77ef212351812, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向：癌症;表观遗传修饰;综述<br>经验分享：已经外审1个多月了，依然没有任何消息，着急的勿投！听说换了出版商，依然很慢，接受了依然未online呀<br>2023.1.28投稿，因格式问题退回修改，过年有事耽误，2023.2.20返回，2023.2.23外审，一直到现在，，，，，外审中。。。。。何时有结果，天知道, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=131, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6ea06468665, createdName=小中医7519, createdTime=Mon Apr 03 17:05:48 CST 2023, time=2023-04-03, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2095357, encodeId=dd2e209535ef3, content=投稿一个多月 还是submit to journal, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=14455530460, createdName=ZNB, createdTime=Sat Oct 22 12:32:00 CST 2022, time=2022-10-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1189040, encodeId=7f9711890406e, content=垃圾 想着国外 投稿三周了没消息 发邮件问不会 直接撤回了 浪费时间, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=56665685878, createdName=ms4000001286605589, createdTime=Sat Jan 29 09:53:50 CST 2022, time=2022-01-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2158337, encodeId=ed29215833e0c, content=审稿速度:3.0 | 投稿命中率:75.0<br>偏重的研究方向：癌症;表观遗传;耐药<br>经验分享：4月份接受，7月出官网online，但到10月份这个也检索不到，问编辑说到明年1月份WOSonline，今年国家奖学金没了，三篇1区SCI，7.4，7.5，6.8，还有中文核心4篇, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=302, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6ea06468665, createdName=小中医7519, createdTime=Mon Sep 18 21:00:36 CST 2023, time=2023-09-18, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2172360, encodeId=feea21e2360a5, content=审稿速度:1.0 | 投稿命中率:75.0<br>经验分享：请问投过这个杂志的前辈都是多久online的，7月4号接收，7月18号就完成了校稿，也交过了版面费，但是都四个多月了一直没有online，检索不到，发邮件给的回复是他也回答不了这个问题，大概要等多久啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=261, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a37c5495661, createdName=whynot6688, createdTime=Fri Dec 01 15:59:33 CST 2023, time=2023-12-01, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=800506, encodeId=42d680050654, content=本刊论文被重庆医科大学包圆了，内容五花八门，低劣水平居多，且很多跟刊物主题相关度不大。强烈建议改名：重庆医科大学学报（英文版）！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=210, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e9e32216429, createdName=pendrin_89355954, createdTime=Tue Jun 30 08:28:03 CST 2020, time=2020-06-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1203114, encodeId=fe7e1203114c9, content=审稿速度:12.0 | 投稿命中率:25.0<br>经验分享：22年的文章很多都是20年接受的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=192, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f0ee5612681, createdName=ms2000001542264371, createdTime=Wed Mar 16 14:46:06 CST 2022, time=2022-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2166032, encodeId=2524216603269, content=请教一下没有under review 就Decision in Process是要被拒了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e06e2311249, createdName=328674612_67739431, createdTime=Wed Nov 01 10:51:38 CST 2023, time=2023-11-01, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2138652, encodeId=a343213865266, content=请教各位前辈们，我查了官网没有发现投稿文章文本的格式，是对字体字号没要求吗。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=266, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c8478710310, createdName=ms6000000438436254, createdTime=Tue May 23 20:28:59 CST 2023, time=2023-05-23, status=1, ipAttribution=广东省)]
    2023-11-01 328674612_67739431 来自北京

    请教一下没有under review 就Decision in Process是要被拒了吗？

    1

    展开1条回复
  10. [GetPortalCommentsPageByObjectIdResponse(id=2145950, encodeId=43082145950e8, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向：hematology<br>经验分享：23-1-28投，2-9建议改rapid communication，2-23改好投回去，2-28under review，4-5minor revise，中间因为事情多延期2月补实验，6-18修回，6-24accept。目前没进一步消息。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=255, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=65db1735433, createdName=1def9298m50(暂无匿称), createdTime=Sun Jul 02 13:26:39 CST 2023, time=2023-07-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2123518, encodeId=77ef212351812, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向：癌症;表观遗传修饰;综述<br>经验分享：已经外审1个多月了，依然没有任何消息，着急的勿投！听说换了出版商，依然很慢，接受了依然未online呀<br>2023.1.28投稿，因格式问题退回修改，过年有事耽误，2023.2.20返回，2023.2.23外审，一直到现在，，，，，外审中。。。。。何时有结果，天知道, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=131, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6ea06468665, createdName=小中医7519, createdTime=Mon Apr 03 17:05:48 CST 2023, time=2023-04-03, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2095357, encodeId=dd2e209535ef3, content=投稿一个多月 还是submit to journal, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=14455530460, createdName=ZNB, createdTime=Sat Oct 22 12:32:00 CST 2022, time=2022-10-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1189040, encodeId=7f9711890406e, content=垃圾 想着国外 投稿三周了没消息 发邮件问不会 直接撤回了 浪费时间, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=56665685878, createdName=ms4000001286605589, createdTime=Sat Jan 29 09:53:50 CST 2022, time=2022-01-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2158337, encodeId=ed29215833e0c, content=审稿速度:3.0 | 投稿命中率:75.0<br>偏重的研究方向：癌症;表观遗传;耐药<br>经验分享：4月份接受，7月出官网online，但到10月份这个也检索不到，问编辑说到明年1月份WOSonline，今年国家奖学金没了，三篇1区SCI，7.4，7.5，6.8，还有中文核心4篇, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=302, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6ea06468665, createdName=小中医7519, createdTime=Mon Sep 18 21:00:36 CST 2023, time=2023-09-18, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2172360, encodeId=feea21e2360a5, content=审稿速度:1.0 | 投稿命中率:75.0<br>经验分享：请问投过这个杂志的前辈都是多久online的，7月4号接收，7月18号就完成了校稿，也交过了版面费，但是都四个多月了一直没有online，检索不到，发邮件给的回复是他也回答不了这个问题，大概要等多久啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=261, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a37c5495661, createdName=whynot6688, createdTime=Fri Dec 01 15:59:33 CST 2023, time=2023-12-01, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=800506, encodeId=42d680050654, content=本刊论文被重庆医科大学包圆了，内容五花八门，低劣水平居多，且很多跟刊物主题相关度不大。强烈建议改名：重庆医科大学学报（英文版）！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=210, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e9e32216429, createdName=pendrin_89355954, createdTime=Tue Jun 30 08:28:03 CST 2020, time=2020-06-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1203114, encodeId=fe7e1203114c9, content=审稿速度:12.0 | 投稿命中率:25.0<br>经验分享：22年的文章很多都是20年接受的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=192, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f0ee5612681, createdName=ms2000001542264371, createdTime=Wed Mar 16 14:46:06 CST 2022, time=2022-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2166032, encodeId=2524216603269, content=请教一下没有under review 就Decision in Process是要被拒了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e06e2311249, createdName=328674612_67739431, createdTime=Wed Nov 01 10:51:38 CST 2023, time=2023-11-01, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2138652, encodeId=a343213865266, content=请教各位前辈们，我查了官网没有发现投稿文章文本的格式，是对字体字号没要求吗。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=266, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c8478710310, createdName=ms6000000438436254, createdTime=Tue May 23 20:28:59 CST 2023, time=2023-05-23, status=1, ipAttribution=广东省)]
    2023-05-23 ms6000000438436254 来自广东省

    请教各位前辈们，我查了官网没有发现投稿文章文本的格式，是对字体字号没要求吗。

    1

    展开1条回复
共151条页码: 2/16页10条/页
分享您的投稿经验，提升MI经验值，获取更多积分